The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Dopamine D2 Receptor Imaging with SPECT: Studies in Different Neuropsychiatric Disorders
Open accessAbstract
The purpose of the present study is to visualize and quantify dopamine D2 receptors in the living human brain using an 123 I-labeled ligand and the single photon emission computerized tomography (SPECT) technique. S-(–)-Iodobenzamide [ S-(–)-IBZM] has been shown to be a highly selective ligand with high affinity for D2 receptors in experimental studies. Five millicuries (185 MBq) of 123 I-labeled S-(–)-IBZM was administered intravenously to 12 control subjects, 22 parkinsonian patients under L-Dopa therapy, 12 parkinsonian patients without L-Dopa, 10 unmedicated patients with Huntington's disease, and 12 patients under different neuroleptics. Data collection with a rotating double-head scintillation camera started 1 h after injection and lasted for 50 min. In a semiquantitative approach, a ratio was calculated between mean counts per pixel in the striatum and a region in the lateral frontal cortex, which was 1.74 ± 0.10 in the control group. A marked reduction of this ratio was found in patients with Huntington's disease (1.38 ± 0.12; p = 0.0001), no significant changes in untreated parkinsonian patients (1.67 ± 0.14), but a reduction in L-Dopa-treated cases (1.59 ± 0.13; p = 0.0014). A curvilinear relationship was found between total daily dose of neuroleptics and the reduction of this ratio. Estimated receptor blockade under full neuroleptic treatment was 75–80%. S-(–)-IBZM binding was reduced with increasing age (p < 0.01). Specific binding was reduced markedly when the racemic mixture of IBZM was used, and no specific binding was seen with the R-(+)-isomer, demonstrating the stereoselectivity of IBZM binding. The results show that dopamine D2 receptors can be clearly visualized with high resolution using the SPECT technique and S-(–)-IBZM as a ligand. A semiquantitative approach can give estimates for receptor blockade or receptor density. This method is of clinical value for the diagnosis of degenerative neurological disorders such as Huntington's disease and for the monitoring of neuroleptic treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atrophy of medium spiny I striatal dendrites in advanced Parkinson's disease
McNeill, T. H., Brown, S. A., Rafols, J. A., & Shoulson, I. (1988) · Brain Research · doi:10.1016/0006-8993(88)90124-2 · Cited by 246
Cited by
Glutamate and dopamine in schizophrenia: An update for the 21 st century
Howes, O., McCutcheon, R., & Stone, J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114563634 · Cited by 702
Brooks, D. J., Ibanez, V., Sawle, G. V., Playford, E. D., Quinn, N., Mathias, C. J., Lees, A. J., Marsden, C. D., Bannister, R., & Frackowiak, R. S. J. (1992) · Annals of Neurology · doi:10.1002/ana.410310209 · Cited by 396
Dopamine D2 receptors in depression measured with single photon emission computed tomography
D'haenen, H. A., & Bossuyt, A. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)91202-5 · Cited by 189
Berding, G., Müller-Vahl, K., Schneider, U., Gielow, P., Fitschen, J., Stuhrmann, M., Harke, H., Buchert, R., Donnerstag, F., Hofmann, M., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.01.005 · Cited by 54
Schizotypy trait and striatal dopamine receptors in healthy volunteers
Chen, K. C., Lee, I. H., Yeh, T. L., Chiu, N. T., Chen, P. S., Yang, Y. K., Lu, R.-B., & Chen, C. C. (2012) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2011.07.003 · Cited by 21
Metadata
- Authors
- Brücke, T., Podreka, I., Angelberger, P., Wenger, S., Topitz, A., Küfferle, B., Müller, C., & Deecke, L.
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 1991-03
- Volume
- 11
- Issue
- 2
- Pages
- 220-228
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- OpenAlex
- W2019058368
- Cited by
- 206
- References
- 1
- FWCI
- 6.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dopamine D2 Receptor Imaging with SPECT: Studies in Different Neuropsychiatric Disorders. https://app.cochat.ai/papers/10.1038/jcbfm.1991.53
- The paper
- Brücke, T., Podreka, I., Angelberger, P., Wenger, S., Topitz, A., Küfferle, B., Müller, C., & Deecke, L. (1991). Dopamine D2 Receptor Imaging with SPECT: Studies in Different Neuropsychiatric Disorders. Journal of Cerebral Blood Flow & Metabolism. https://doi.org/10.1038/jcbfm.1991.53
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.